Qure Ventures
Overview
Qure Ventures is Israel's first exclusively focused digital health fund, concentrating on early-stage deep-tech solutions. The firm invests in startups that have developed disruptive solutions using machine vision, neuro-tech, digital therapeutics, artificial intelligence, cybersecurity, and big-data analytics. Qure Ventures has established strategic partnerships with key stakeholders in consumer, provider, payer, and pharma domains, providing fast-track access to market and clinical validation opportunities for its portfolio companies. The fund predominantly focuses on startups located in Israel, leveraging the country's leading tech and digital health ecosystem. Managed by Dr. Yossi Bahagon and Allen Kamer, Qure Ventures benefits from OurCrowd's global network, investment leadership, and in-house medical expertise, offering unparalleled deal access and robust diligence. Qure Ventures was established in 2016 and is managed by Dr. Yossi Bahagon and Allen Kamer. The firm has invested in several companies, including BrainQ, a company developing AI-driven solutions for neurological rehabilitation. Qure Ventures aims to revolutionize healthcare delivery by supporting innovative digital health solutions that empower individuals to actively manage their health, improve clinical outcomes, reduce costs, and enhance patient-physician relationships.
Reach Qure Ventures directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Qure Ventures
What sectors does Qure Ventures invest in?
Qure Ventures invests in Technology and Healthcare, and is based in Israel. Qure Ventures is listed as a vc in the ConnectSafely investor database.
What stage does Qure Ventures invest at?
Qure Ventures backs companies at Seed and Early Stage.
Which regions does Qure Ventures invest in?
Qure Ventures invests across Israel.
Last updated · Source: ConnectSafely investor database
